Dr. Bangkim Chandra Khangembam did his MD in Nuclear Medicine from All India Institute of Medical Sciences, New Delhi. He worked as Assistant Professor at Dr. B. Borooah Cancer Institute, Guwahati (Regional Cancer Institute), a unit of Tata Memorial Centre, Mumbai. He Started and established the first dedicated Nuclear Medicine department with radioiodine therapy facility for thyroid cancer in north-east India. He also designed the first and only high-dose Nuclear Medicine therapy ward (3-bedded) of north-east India and also took the forefront role in getting the said facility commissioned. He has experience in routine and research oriented Diagnostic Nuclear Medicine Imaging with SPECT-CT (Gamma Camera) and PET-CT, and Therapeutic Nuclear Medicine including radioiodine therapy, PRRT, bone pain palliation therapy, radiosynovectomy, MIBG therapy etc. Dr. Khangembam is also a Fellow of the Asian Nuclear Medicine Board (FANMB).
Number of publications
Scientific Session by Prof. J. Harvey Turner (Nuclear Medicine Oncologist, University of Western Australia) on “Role of radioisotope therapy in low-grade lymphomas” at the Indian Habitat Center on Nov 26, 2018.